Exclusive

Publication

Byline

Location

First fibrotic disease drug of Singapore advances into Phase II clinical evaluation

Singapore, Jan. 21 -- Duke-NUS Medical School in Singapore has noted theannouncement by Boehringer Ingelheimof a Phase IIa clinical study evaluating BI 765423, a first-in-class IL-11 inhibitor for idi... Read More


AstraZeneca buys remaining China rights to GPC3 armored CAR-T therapy from AbelZeta Pharma for $630 M

Singapore, Jan. 21 -- US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic pr... Read More


Pacira partners with LG Chem to make EXPAREL(R) available in select APAC markets

Singapore, Jan. 21 -- US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to opioid-sparing postsurgical pain control for patients in s... Read More


GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare

Singapore, Jan. 21 -- GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK-based ViiV Healthcare Limited, currently held by Pfizer to be... Read More


Dentalkart inks strategic partnership with NSK Japan to strengthen access to authentic dental technology in India

Singapore, Jan. 19 -- Dentalkart, India's largest online marketplace for dental products, has announced a strategic partnership with NSK Japan, a global leader in dental rotary instruments and precisi... Read More


China's Zonsen PepLib Biotech inks $50 M deal with Novartis for Radioligand Therapy Asset

Singapore, Jan. 19 -- China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in the field of radioligand the... Read More


AdCella and Shanghai Cell Therapy Group launch global collaboration on groundbreaking cancer therapy

Singapore, Jan. 15 -- Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular immunotherapy subsidiary, AdCella have signed a major develop... Read More


ElpasBio and Fosun Kairos collaborate to commercialise AlloJoin(R) stem cell therapy

Singapore, Jan. 15 -- China-based startup ElpasBio Holdings, a leading clinical-stage biotechnology company focused on regenerative medicine, has entered into a collaboration agreement with Fosun Kair... Read More


Rakuten Medical and Lotte Biologics ink agreement to support biopharma in global oncology programme

Singapore, Jan. 14 -- US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing agreement duringthe J.P. Morgan Healthcare Conferencein Sa... Read More


Taiwan's Leadgene Biosolutions expands product portfolio for metabolic research

Singapore, Jan. 14 -- Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfol... Read More